Weronika J. Kurowska

Warsaw, MZ 02637, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment.

Correction: Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment.

Journal: The journal of headache and pain

Published: December 12, 2025

Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment.

Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment.

Journal: The journal of headache and pain

Published: March 23, 2025

Significance of miRNA Profile of Regulatory T Cells (Tregs) After Baricitinib Treatment in Rheumatoid Arthritis Patients.

Significance of miRNA Profile of Regulatory T Cells (Tregs) After Baricitinib Treatment in Rheumatoid Arthritis Patients.

Journal: European journal of immunology

Published: January 28, 2025

Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Activation and Cytokine Production.

Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Activation and Cytokine Production.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: November 15, 2024

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients.

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients.

Journal: Pharmaceutics

Published: February 11, 2023

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis.

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis.

Journal: Journal of clinical medicine

Published: March 17, 2021

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development.

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development.

Journal: Journal of clinical medicine

Published: April 29, 2020

CD4+FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired.

CD4+FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired.

Journal: Cells

Published: December 13, 2019

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients - a pilot study.

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients - a pilot study.

Journal: Reumatologia

Published: January 08, 2018

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.

Journal: Central-European journal of immunology

Published: May 11, 2017

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.

Journal: Annals of the rheumatic diseases

Published: April 13, 2017

Rheumatoid arthritis bone marrow environment supports Th17 response.

Rheumatoid arthritis bone marrow environment supports Th17 response.

Journal: Arthritis research & therapy

Published: February 16, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026